The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19

NCT04591704 | Unknown

• 1 other identifier: UU-DM003
• Study Type: observational
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study. The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Conditions

Covid19; Diabetes Mellitus

Outcome Measures

Primary Outcomes (4)

• Duration of Hospitalisation

  The time between admission to hospital and discharge

  1 year

• The need for ICU

  The admission of hospitalized patients to the intensive care unit.

  1 year

• Mortality

  Mortality rates of patients

  1 year

• Lung involvement

  The presence of lung involvement on thorax CT

  1 year

Study Arms (2)

Diabetic groups

COVID-19 patients with diabetes mellitus

Other: hospitalisation, necessity of ICU, mortality rate, lung involvement

Control groups

COVID-19 patients without diabetes mellitus

Other: hospitalisation, necessity of ICU, mortality rate, lung involvement

Interventions

hospitalisation, necessity of ICU, mortality rate, lung involvement OTHER

hospitalisation, necessity of ICU, mortality rate, lung involvement

Control groups; Diabetic groups

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients aged between 18-80 years, diagnosed and hospitalised for COVID-19 will be enrolled in to the study

You may qualify if:

• Patients hospitalized for COVID-19

You may not qualify if:

• Patients with known malignancy
• Pregnant patients

Sponsors & Collaborators

• Uşak University: lead

Study Sites (1)

Usak University Training and Research Hospital

Uşak, 64200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

COVID-19; Diabetes Mellitus

Interventions

Hospitalization; Mortality

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Patient Care; Therapeutics; Health Services; Health Care Facilities Workforce and Services; Vital Statistics; Data Collection; Epidemiologic Methods; Investigative Techniques; Demography; Population Characteristics; Epidemiologic Measurements; Public Health; Environment and Public Health

Study Officials

• Cevdet Duran

  Uşak Üniversitesi Tıp fak

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Cevdet Duran

CONTACT

02762212121; drcduran@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 16, 2020
• First Posted: October 19, 2020
• Study Start: March 20, 2020
• Primary Completion: October 15, 2020
• Study Completion: July 1, 2021
• Last Updated: May 4, 2021

Record last verified: 2021-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)